Beta Bionics, Inc. (BBNX) Return on Equity (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Equity rose 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 1.0% YoY) and the FY2025 annual result came in at 0.03%, down 3.0% from the prior year.
• Return on Equity retreated to 0.0% in Q1 2026 per BBNX's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q4 2024, with the low at 0.01% in Q1 2025.
• Average Return on Equity over 3 years is 0.0%, with a median of 0.0% recorded in 2025.
• Year-over-year, Return on Equity changed 0 bps in 2025 and advanced 1 bps in 2026.
• Beta Bionics' Return on Equity stood at 0.0% in 2024, then slumped by 220 bps to 0.0% in 2025, then slipped by 14 bps to 0.0% in 2026.
• Business Quant data shows BBNX's Return on Equity at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.